The regulatory roles and clinical significance of glycolysis in tumor
Top Cited Papers
Open Access
- 8 June 2024
- journal article
- review article
- Published by American Association for the Advancement of Science (AAAS) in Cancer Communications
- Vol. 44 (7) , 761-786
Abstract
Metabolic reprogramming has been demonstrated to have a significant impact on the biological behaviors of tumor cells, among which glycolysis is an important form. Recent research has revealed that the heightened glycolysis levels, the abnormal expression of glycolytic enzymes, and the accumulation of glycolytic products could regulate the growth, proliferation, invasion, and metastasis of tumor cells and provide a favorable microenvironment for tumor development and progression. Based on the distinctive glycolytic characteristics of tumor cells, novel imaging tests have been developed to evaluate tumor proliferation and metastasis. In addition, glycolytic enzymes have been found to serve as promising biomarkers in tumor, which could provide assistance in the early diagnosis and prognostic assessment of tumor patients. Numerous glycolytic enzymes have been identified as potential therapeutic targets for tumor treatment, and various small molecule inhibitors targeting glycolytic enzymes have been developed to inhibit tumor development and some of them are already applied in the clinic. In this review, we systematically summarized recent advances of the regulatory roles of glycolysis in tumor progression and highlighted the potential clinical significance of glycolytic enzymes and products as novel biomarkers and therapeutic targets in tumor treatment.Keywords
Funding Information
- National Natural Science Foundation (82270200)
- National Natural Science Foundation (82070203)
- National Natural Science Foundation (81770210)
- Natural Science Foundation of Shandong Province (ZR2023QH193)
- Key Technology Research and Development Program of Shandong Province (2018CXGC1213)
- China Postdoctoral Science Foundation (No. 2023M741506)
This publication has 254 references indexed in Scilit:
- Aerobic glycolysis promotes tumor immune evasion and tumor cell stemness through the noncanonical function of hexokinase 2Cancer Communications, 2023
- A non‐metabolic function of hexokinase 2 in small cell lung cancer: promotes cancer cell stemness by increasing USP11‐mediated CD133 stabilityCancer Communications, 2022
- Therapeutic targeting of SPIB/SPI1‐facilitated interplay of cancer cells and neutrophils inhibits aerobic glycolysis and cancer progressionClinical and Translational Medicine, 2021
- Targeting lactate dehydrogenase A ( LDHA ) exerts antileukemic effects on T‐cell acute lymphoblastic leukemiaCancer Communications, 2020
- Expression of hypoxia‐inducible factor 1α, glucose transporter 1, and hexokinase 2 in primary central nervous system lymphoma and the correlation with the biological behaviorsBrain and Behavior, 2020
- Discovery of a Potent GLUT Inhibitor from a Library of Rapafucins by Using 3D MicroarraysAngewandte Chemie International Edition, 2019
- Lactate dehydrogenase A: A key player in carcinogenesis and potential target in cancer therapyCancer Medicine, 2018
- Novel therapeutic roles of MC ‐4 in combination with everolimus against advanced renal cell carcinoma by dual targeting of Akt/pyruvate kinase muscle isozyme M2 and mechanistic target of rapamycin complex 1 pathwaysCancer Medicine, 2018
- Acetylation of PGK1 promotes liver cancer cell proliferation and tumorigenesisHepatology, 2016
- Osteosarcoma and Other Neoplasms of BoneArchives of Surgery, 1987